id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-D-0081-0001,FDA,FDA-1999-D-0081,"Draft ""Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;"" Availability",Notice,Notice of Data Availability,1999-11-03T05:00:00Z,1999,11,1999-11-03T05:00:00Z,2000-02-02T04:59:59Z,2025-07-01T20:17:52Z,99-28560,0,0,09000064804a694a